A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease

Table 3 Treatment modalities in men with PCa from clinical registries in SA and Victoria, stratified by NCCN risk group

NCCN Risk	Low*		Intermediate*		High*		V.high/Metastasis*		Total
NCCN Risk	N	%	N	%	N	%	N	%	N	%
RP	1,164	34.7	3,097	54.1	988	33.6	57	10.4	5,306	42.2
RT	418	12.5	1,263	22.1	958	32.6	153	28.0	2,792	22.2
ADT	18	0.5	114	2.0	469	15.9	219	40.1	820	6.5
No active treatment	1,483	44.2	723	12.6	225	7.6	18	3.3	2,449	19.5
Other	154	4.6	307	5.4	194	6.6	45	8.2	700	5.6
Unknown	115	3.4	223	3.9	109	3.7	54	9.9	501	4.0
Total	3,352	100	5,727	100	2,943	100	546	100	12,568	100
Median [IQR] days to treatment	119 [63–222.5]		80 [48–137]		49 [29–96]		31 [12–71.5]		75 [41–142]

NCCN National Comprehensive Cancer Network, RP Radical prostatectomy, RT radiotherapy, ADT Androgen Deprivation Therapy
*p < 0.05

ISSN: 1471-2407